These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillation. McBane RD; Hodge DO; Wysokinski WE Thromb Haemost; 2008 May; 99(5):951-5. PubMed ID: 18449427 [TBL] [Abstract][Full Text] [Related]
9. The natural history of lone atrial flutter. Halligan SC; Gersh BJ; Brown RD; Rosales AG; Munger TM; Shen WK; Hammill SC; Friedman PA Ann Intern Med; 2004 Feb; 140(4):265-8. PubMed ID: 14970149 [TBL] [Abstract][Full Text] [Related]
10. [Value of transesophageal echocardiography in the therapeutic management of non-valvular atrial fibrillation]. Baubion N Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1291-5. PubMed ID: 8952827 [TBL] [Abstract][Full Text] [Related]
11. [Comparative incidence of protrusive atheromatous plaques of the thoracic artery in patients with atrial fluter and atrial fibrillation]. Boccara F; Rozenberg V; Buyukoglu B; Smadja C; Bardet J; Cohen A Arch Mal Coeur Vaiss; 2001 Jan; 94(1):16-22. PubMed ID: 11233476 [TBL] [Abstract][Full Text] [Related]
12. Cardioversion of persistent atrial flutter in non-anticoagulated patients at low risk for thromboembolism. Bertaglia E; D'Este D; Franceschi M; Pascotto P Ital Heart J; 2000 May; 1(5):349-53. PubMed ID: 10832811 [TBL] [Abstract][Full Text] [Related]
13. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative]. Själander A; Wallentin L; Rosenqvist M; Svensson P Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862 [No Abstract] [Full Text] [Related]
14. Summaries for patients. Outcomes of patients with lone atrial flutter. Ann Intern Med; 2004 Feb; 140(4):I55. PubMed ID: 14970172 [No Abstract] [Full Text] [Related]
15. [Thromboembolic risk factors in atrial flutter. Transesophageal echocardiographic study]. Thumala A; Parra C; Maragaño P; Puelma A; Florenzano F Rev Med Chil; 2000 Dec; 128(12):1327-34. PubMed ID: 11227241 [TBL] [Abstract][Full Text] [Related]
16. How to define valvular atrial fibrillation? Fauchier L; Philippart R; Clementy N; Bourguignon T; Angoulvant D; Ivanes F; Babuty D; Bernard A Arch Cardiovasc Dis; 2015 Oct; 108(10):530-9. PubMed ID: 26184867 [TBL] [Abstract][Full Text] [Related]
17. Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Thambidorai SK; Murray RD; Parakh K; Shah TK; Black IW; Jasper SE; Li J; Apperson-Hansen C; Asher CR; Grimm RA; Klein AL; Am J Cardiol; 2005 Oct; 96(7):935-41. PubMed ID: 16188520 [TBL] [Abstract][Full Text] [Related]
18. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. Manning WJ; Silverman DI; Keighley CS; Oettgen P; Douglas PS J Am Coll Cardiol; 1995 May; 25(6):1354-61. PubMed ID: 7722133 [TBL] [Abstract][Full Text] [Related]
19. [Risk stratification tools for evaluating thromboembolic risk in atrial fibrillation]. Ouardiri Y; Marti C; Carballo S; Garin N Rev Med Suisse; 2011 Feb; 7(280):313-6, 318-9. PubMed ID: 21381276 [TBL] [Abstract][Full Text] [Related]
20. Transesophageal echocardiography and atrial fibrillation: added value or expensive toy? Manning WJ; Douglas PS Ann Intern Med; 1998 Apr; 128(8):685-7. PubMed ID: 9537943 [No Abstract] [Full Text] [Related] [Next] [New Search]